Correlation Between Serum IL-1β Level in Rheumatoid Arthritis Patients and Some Clinical and Sociodemographic Characteristics
DOI:
https://doi.org/10.36320/ajb/v16.i3.17234Keywords:
IL-1β, Rheumatoid arthritis, ELISA, SociodemographicAbstract
IL-1β is a potent pro-inflammatory cytokine, mainly produced by activated macrophages and monocytes. It induces adhesion molecules, promotes increased leukocyte infiltration, and releases other pro-inflammatory mediators. High levels of IL-1β have been found in RA patients, both in synovial fluid and serum. This study aimed to examine the serum level of IL-1β in RA patients compared with controls and their association with clinical and sociodemographic characteristics. Seventy-one patients with RA and forty-six healthy controls were recruited from the Iraqi Arab population in this case-control study. Measurement of the serum IL-1β level was done in this study using an Enzyme-Linked Immunosorbent Assay kit. According to the analysis, these results indicated that there is a significant increase in the serum level of IL-1β in RA patients compared to that in the control, (p = 0.039). Also, IL-1β concentration in RA smoker patients increased significantly compared to RA non-smoker patients (p=0.045). In conclusion, serum IL-1β levels were significantly associated with RA disease in the Iraqi Arab population and may regarded as a diagnostic marker for RA diagnosis especially in smokers’ patients.
Downloads
References
Sabet, M. N., Nasrabadi, N., Jalili, Z., Pakzad, B., Davar, S., Ehtesham, N., Jafarpour, S., Mosallaei, M., & Esmaeilzadeh, E. (2021). Association of Polymorphisms in the NLRP3 Gene and Rheumatoid Arthritis in Iranian Patients. Iranian Journal of Immunology, 18(3), 249–258. https://doi.org/10.22034/iji.2021.89507.1950
Ding, Q., Hu, W., Wang, R., Yang, Q., Zhu, M., Li, M., Cai, J., Rose, P., Mao, J., & Zhu, Y. Z. (2023). Signaling pathways in rheumatoid arthritis: implications for targeted therapy. In Signal Transduction and Targeted Therapy (Vol. 8, Issue 1). Springer Nature. https://doi.org/10.1038/s41392-023-01331-9
Prasad, P., Verma, S., Surbhi, Ganguly, N. K., Chaturvedi, V., & Mittal, S. A. (2023). Rheumatoid arthritis: advances in treatment strategies. Molecular and Cellular Biochemistry, 478(1), 69–88. https://doi.org/10.1007/s11010-022-04492-3
Su, J., Hu, W., Ding, Y., Zhang, P., Li, T., Liu, S., & Xing, L. (2024). Serum GM-CSF level is a predictor of treatment response to tocilizumab in rheumatoid arthritis patients: a prospective observational cohort study. Arthritis Research & Therapy, 26(1), 130. https://doi.org/10.1186/s13075-024-03373-yhttps://doi.org/10.1007/s00296-015-3379-x
Lopez-Castejon, G., & Brough, D. (2011). Understanding the mechanism of IL-1β secretion. Cytokine & Growth Factor Reviews, 22(4), 189–195. https://doi.org/10.1016/j.cytogfr.2011.10.001
Kondo, N., Kuroda, T., & Kobayashi, D. (2021). Cytokine networks in the pathogenesis of rheumatoid arthritis. In International Journal of Molecular Sciences (Vol. 22, Issue 20). MDPI. https://doi.org/10.3390/ijms222010922
Cronstein, B. N., & Sitkovsky, M. (2017). Adenosine and adenosine receptors in the pathogenesis and treatment of rheumatic diseases. Nature Reviews Rheumatology, 13(1), 41–51. https://doi.org/10.1038/nrrheum.2016.178
Weinblatt, M. E., Fleischmann, R., Huizinga, T. W. J., Emery, P., Pope, J., Massarotti, E. M., van Vollenhoven, R. F., Wollenhaupt, J., Bingham, C. O., Duncan, B., Goel, N., Davies, O. R., & Dougados, M. (2012). Efficacy and safety of certolizumab pegol in a broad population of patients with active rheumatoid arthritis: results from the REALISTIC phase IIIb study. Rheumatology, 51(12), 2204–2214. https://doi.org/10.1093/rheumatology/kes150
Okano, T., Inui, K., Tada, M., Sugioka, Y., Mamoto, K., Wakitani, S., Koike, T., & Nakamura, H. (2016). Levels of interleukin-1 beta can predict response to tocilizumab therapy in rheumatoid arthritis: the PETITE (predictors of effectiveness of tocilizumab therapy) study. Rheumatology International, 36(3), 349–357. https://doi.org/10.1007/s00296-015-3379-x
Bedaiwi, M. K., Almaghlouth, I., & Omair, M. A. (2021). Effectiveness and adverse effects of anakinra in the treatment of rheumatoid arthritis: a systematic review. European Review for Medical and Pharmacological Sciences, 25(24), 7833–7839. https://doi.org/10.26355/eurrev_202112_27630
Jiang, Q., Wang, X., Xu, X., Hu, L., Zhou, G., Liu, R., Yang, G., & Cui, D. (2023). Inflammasomes in rheumatoid arthritis: a pilot study. BMC Rheumatology, 7(1), 39. https://doi.org/10.1186/s41927-023-00353-8
Cheng, L., Liang, X., Qian, L., Luo, C., & Li, D. (2021). NLRP3 gene polymorphisms and expression in rheumatoid arthritis. Experimental and Therapeutic Medicine, 22(4), 1110. https://doi.org/10.3892/etm.2021.10544
Kobayashi, T., Yokoyama, T., Ishida, K., Abe, A., Yamamoto, K., & Yoshie, H. (2010). Serum Cytokine and Periodontal Profiles in Relation to Disease Activity of Rheumatoid Arthritis in Japanese Adults. Journal of Periodontology, 81(5), 650–657. https://doi.org/10.1902/jop.2010.090688
Chen, P.-K., Tang, K.-T., & Chen, D.-Y. (2024). The NLRP3 Inflammasome as a Pathogenic Player Showing Therapeutic Potential in Rheumatoid Arthritis and Its Comorbidities: A Narrative Review. International Journal of Molecular Sciences, 25(1), 626. https://doi.org/10.3390/ijms25010626
Firestein, G. S., & McInnes, I. B. (2017). Immunopathogenesis of Rheumatoid Arthritis. Immunity, 46(2), 183–196. https://doi.org/10.1016/j.immuni.2017.02.006
Jang, Sunhee, Kwon, E. J., & Lee, J. J. (2022). Rheumatoid Arthritis: Pathogenic Roles of Diverse Immune Cells. In International Journal of Molecular Sciences (Vol. 23, Issue 2). MDPI. https://doi.org/10.3390/ijms23020905
Adachi, M., Okamoto, S., Chujyo, S., Arakawa, T., Yokoyama, M., Yamada, K., Hayashi, A., Akita, K., Takeno, M., Itoh, S., Takii, T., Waguri-Nagaya, Y., Otsuka, T., Hayakawa, K., Miyazawa, K., & Onozaki, K. (2013). Cigarette smoke condensate extracts induce il-1-beta production from rheumatoid arthritis patient-derived synoviocytes, but not osteoarthritis patient-derived synoviocytes, through aryl hydrocarbon receptor-dependent NF-kappa-B activation and novel NF-kappa-B sites. Journal of Interferon and Cytokine Research, 33(6), 297–307. https://doi.org/10.1089/jir.2012.0107
Gao, J., Zhang, H., Yang, Y., & Tao, J. (2023). Therapeutic Potential of Targeting the NLRP3 Inflammasome in Rheumatoid Arthritis. Inflammation, 46(3), 835–852. https://doi.org/10.1007/s10753-023-01795-5
Shoda, H., Nagafuchi, Y., Tsuchida, Y., Sakurai, K., Sumitomo, S., Fujio, K., & Yamamoto, K. (2017). Increased serum concentrations of IL-1 beta, IL-21, and Th17 cells in overweight patients with rheumatoid arthritis. Arthritis Research & Therapy, 19(1), 111. https://doi.org/10.1186/s13075-017-1308-y
Dinarello, C. A. (2019). The IL-1 family of cytokines and receptors in rheumatic diseases. In Nature Reviews Rheumatology (Vol. 15, Issue 10, pp. 612–632). Nature Publishing Group. https://doi.org/10.1038/s41584-019-0277-8
Arend, W. P., & Firestein, G. S. (2012). Pre-rheumatoid arthritis: predisposition and transition to clinical synovitis. Nature Reviews Rheumatology, 8(10), 573–586. https://doi.org/10.1038/nrrheum.2012.134
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Hussein Ali Salih, Karrar S. Zayed
This work is licensed under a Creative Commons Attribution 4.0 International License.
which allows users to copy, create extracts, abstracts, and new works from the Article, alter and revise the Article, and make commercial use of the Article (including reuse and/or resale of the Article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made and the licensor is not represented as endorsing the use made of the work.
